Stock Events

Stock Events

Lumos Diagnostics 

$0.16
10
-$0-0.93% Thursday 13:35

Statistics

Day High
0.16
Day Low
0.16
52W High
0.24
52W Low
0.01
Volume
7,300
Avg. Volume
54,497
Mkt Cap
125.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 19
$0.01
May 19
$0.01
Sep 18
$0.01
May 18
$0.01
Sep 17
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

26FebExpected
Q4 2021
Q4 2023
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q4 2025
-0.07
-0.05
-0.02
0
Expected EPS
N/A
Actual EPS
-0.008305977610364008

Financials

-57.93%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
24.8MRevenue
-14.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LDXHF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of diagnostics products, including rapid diagnostics which compete directly with Lumos Diagnostics' offerings.
QuidelOrtho
QDEL
Mkt Cap1.83B
Quidel Corporation specializes in diagnostic healthcare solutions similar to Lumos Diagnostics, particularly in the areas of infectious disease testing.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. provides diagnostics products and technologies for women's health, competing in the broader diagnostics market.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. produces and supplies products and systems used for diagnostic testing, which overlaps with the market Lumos Diagnostics serves.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics is a provider of diagnostic information services, which includes products that compete in the same space as Lumos Diagnostics.
Labcorp
LH
Mkt Cap21.08B
Laboratory Corporation of America Holdings operates in the same clinical laboratory services sector, offering diagnostic and testing solutions.
Orasure Technologies
OSUR
Mkt Cap200.4M
OraSure Technologies, Inc. develops, manufactures, and markets point-of-care diagnostic tests, directly competing with Lumos Diagnostics' rapid test kits.
Neogenomics
NEO
Mkt Cap1.26B
NeoGenomics Laboratories specializes in cancer diagnostics and pharma services, providing diagnostic solutions that could overlap with Lumos' offerings.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics offers genetic testing to detect diseases, indirectly competing with Lumos Diagnostics by providing alternative diagnostic solutions.

About

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
Show more...
CEO
Mr. Douglas Ward
Country
AU
ISIN
AU0000157091

Listings

OTC Link
US
LDXHF
AU
AU
LDX.AU
F
DE
7YU.F

0 Comments

Share your thoughts

FAQ

What is Lumos Diagnostics stock price today?▼
The current price of LDXHF is $0.16 USD — it has decreased by -0.93% in the past 24 hours. Watch Lumos Diagnostics stock price performance more closely on the chart.
What is Lumos Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lumos Diagnostics stocks are traded under the ticker LDXHF.
What is Lumos Diagnostics market cap?▼
Today Lumos Diagnostics has the market capitalization of 125.95M
When is the next Lumos Diagnostics earnings date?▼
Lumos Diagnostics is going to release the next earnings report on September 01, 2026.
What were Lumos Diagnostics earnings last quarter?▼
LDXHF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lumos Diagnostics revenue for the last year?▼
Lumos Diagnostics revenue for the last year amounts to 24.8M USD.
What is Lumos Diagnostics net income for the last year?▼
LDXHF net income for the last year is -14.37M USD.
Does Lumos Diagnostics pay dividends?▼
Yes, LDXHF dividends are paid semi-annual. The last dividend per share was 0.3 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Lumos Diagnostics located?▼
Lumos Diagnostics operates in the Health Care sector.
When did Lumos Diagnostics complete a stock split?▼
Lumos Diagnostics has not had any recent stock splits.
Where is Lumos Diagnostics headquartered?▼
Lumos Diagnostics is headquartered in Carlsbad, AU.